HomeMy WebLinkAboutGenentech Annual Report 04-26-2003Annual Report 2003
Presented to the City of South San Francisco
April 26, 2003
Lisa Sullivan -Director Strategic Facilities Planning
Genentech, Inc.
1 DNA Way
South San Francisco, California
Table of Contents
INTRODUCTION .................................................................................................................... 3
Purpose of the Genentech Annual Report ................................................................. 3
The Genentech South San Francisco Campus .......................................................... 3
The Bioscience Industry in South San Francisco ...................................................... 4
GENENTECH & CITY CAMPUS PLANNING .................................................................. 7
Overview of the "R&D Overlay Zone" ...................................................................... 7
How the "R&D Overlay District" Works .................................................................. 7
Public-Private Partnership Benefits ........................................................................... 8
GENENTECH 2002 CAMPUS DEVELOPMENT & BUILDOUT .................................. 12
Genentech Campus Buildout .................................................................................... 12
City of South San Francisco/Genentech Coordination ........................................... 12
2002-03 Accomplishments .........................................................................................
Recent Overlay District Expansion .......................................................................... 13
13
GENENTECH TRANSPORTATION & PARKING MANAGEMENT .......................... 15
Transportation Demand Management Program ....................................................
Audit of the Genentech Parking Inventory .............................................................
Parking Inventory ...................................................................................................... 15
16
16
SAN FRANCISCO /PENINSULA BAY TRAIL ALIGNMENT ..................................... 18
Appendix A .............................................................................................................................
Genentech Research and Development Overlay District Current Facility
Summary April 2003 .................................................................................................. 19
19
Appendix B .............................................................................................................................
Genentech 2002 Parking Audit Apri12003 .............................................................. 22
22
Appendix C .............................................................................................................................
Phase 1 BCDC Bay Trail Alignment April 2003 ..................................................... 26
26
INTRODUCTION
Purpose of the Genentech Annual Report
The City of South San Francisco's "Research and Development Overlay District" and
"Genentech Research and Development Overlay District" regulations require the preparation
of an annual report which
"... shall include, as appropriate, the status of facility-wide improvements,
anticipated new construction or renovation projects, an update on
transportation and parking needs, projected changes in the facility usage and
requirements, advance notice of any proposed changes to the facility-wide
development standards or design guidelines, and notice of any changes that
have been made to the Facility Master Plan... "
Consistent with this requirement, this Annual Report is intended to accomplish several
purposes: (1) Provide background information and up-to-date data on the Genentech campus;
(2) summarize the status of implementing the Genentech Corporate Facilities Master Plan; (3)
identify near-term future projects to the extent possible; (4) provide information for the city to
review the adequacy of the parking needs on the Genentech facility; and (5) provide a basis
for proposing possible modifications to the "Genentech Research and Development Overlay
District" based on the City's and the company's recent experience in implementing these
regulations.
The Genentech South San Francisco Campus
Genentech is the world's first biotechnology company and remains the largest employer in
South San Francisco. The company is a fully integrated bio-pharmaceutical company with its
employees engaged in pharmaceutical research, manufacturing, analytical chemistry and
quality control, marketing and sales, and general corporate and administrative functions and
services. Genentech, Inc. uses human genetic information to discover, develop, manufacture
and market pharmaceuticals.
Genentech's South San Francisco campus is the corporate headquarters and the research and
development center. The Genentech campus is located on 97.3 acres close to San Francisco
three world-class universities (Stanford University, UC Berkeley and UC San Francisco) and
the San Francisco International Airport (SFIA). Genentech currently occupies 28 owned,
leased and temporary buildings in South San Francisco. The Genentech Research &
Development Overlay District currently has 20 permanent buildings and 4 under construction
for approximately 4,000 employees.
The Bioscience Industry in South San Francisco
Twenty-five years ago, Genentech's founders converted an aging warehouse next to the San
Francisco Bay into the first research and development and manufacturing building, beginning
the biotech industry in both the United States and South San Francisco. In 2001, the City of
South San Francisco, the California Healthcare Institute (CHI) and Price Waterhouse Coopers
published "The Bioscience Industry in South San Francisco" report that analyzes the benefits
of the biotech industry cluster in South San Francisco and San Mateo County. The CHI
Report, which updates an earlier analysis of the industry by the Bay Area Bioscience Center
and SAMCEDA, notes that the industry has given the City of South San Francisco worldwide
recognition as the Birthplace of Biotechnology. The biotechnology industry is in its infancy
and is still growing, as evidenced by the construction of the Founders' Research Center II, the
world's largest research facility. The CHI Report also concludes the following:
• The number of biotechnology firms grew from 20 in 1995 to approximately 51 in
2000.
• Biotechnology employment grew nearly 60 percent, from 3,875 in 1995 to 6,150 in
2000.
• During the past five years, the biotechnology industry generated $250 million worth of
construction activity.
• Biotechnology firms in South San Francisco have 70 experimental medicines
undergoing human clinical trials, with a single largest concentration of experiments
(22) aimed at novel treatments for cancer.
• Biotech jobs are diverse and range from basic scientific research in lab settings, to
manufacturing biotechnology products, to business functions such as sales and
marketing, finance, regulatory affairs, quality assurance, human resources, and
procurement.
The CHI Report also notes that the biotechnology industry benefits South San Francisco and
San Mateo County beyond providing high-wage employment and tax revenues. For example,
• Biotechnology firms actively invest and hire in the local community firms participate
in programs that improve the quality of life for residents and business.
• Companies participate in South San Francisco Chamber of Commerce and San Mateo
County's Economic Development programs.
• Companies partner with local government to find solutions to traffic congestion,
providing affordable housing and providing childcare.
• Biotech firms help local high schools and community colleges prepare the skilled
workforce.
• Mentoring programs for local high school and community college students with
degree programs for both technical and professional positions.
• Biotech firms help to outfit the high school and college science labs.
The CHI Report notes that Genentech's economic benefit to South San Francisco and San
Mateo County cannot be underestimated and lists the following direct and indirect benefits
from the company:
Genentech Annual Report 4 April 2003
• Genentech employed approximately 4,000 people at their global headquarters in South
San Francisco.
• 1,868 Genentech employees live in San Mateo County who, in turn, were provided
$143.5 million in salaries.
• Company county property taxes exceeded $8.3 million, the second highest tax payer in
San Mateo County.
• Company purchases from San Mateo County suppliers exceeded $62.8 million,
generating an additional $3.7 million in state sales tax from those purchases.
• Genentech spent $72 million in new construction at the South San Francisco campus,
and created 1,080 temporary construction and skilled trade worker jobs.
• The company contributed $136,000 to San Mateo County-based charitable
organizations in 2002
• During the last 12 years, the company has donated drugs with a total market value of
over $387 million to uninsured or underinsured patients as part of our Access to Care
Foundation.
• In 2002, Genentech contributed approximately $100,000 directly to the City of South
San Francisco downtown merchants through the Genentech Goes to Town program.
Since the program's inception in South San Francisco in 1993, Genentech and its
employees have infused nearly $1 million into our hometown community.
• Genentech sponsors South San Francisco activities to the benefit of local residents and
school children in South San Francisco. In 2002, Genentech's community
involvement included sponsorship of South San Francisco Day in the Park, executive
participation in the Chamber of Commerce as Board president, support of the City's
Positive Attendance Campaign to encourage local school attendance, sponsorship of
the City's Youth in Government Day luncheon, scholarships and internships for local
high school students, and numerous other activities.
Genentech Annual Report 5 April 2003
GENENTECH R & D DIOSTRICT
EXISTING PARCELS
' ~ ~ `,,.
m
~,
.~
~;~
~/ / ~I
+~
/'
~.
~~ I~ -
~.
_ ~:
%,/{ ` i
~ ^ 2 11411[. .1 l~
\ ~
G /'
li' r o
~~ ` It\Sl eb'.
\ ~ ` ' ` U` x
+.,, -~ -
.. it
~ Y
;~
` , a~'
~.
_~
~~~ ~ I ,~
t~
\.V
`~ ~ HI UC io ~ ~~ ~ ~ l ~~•1
,r ~~
~. `'y-v ~ ,v ~ ~s ~ k-y
` ,` \\\
1 ..
~ ,
// , {~
Ii LU(% I ~ \5\~~\~ ~,
R_ f ~
` ..
/// ~
"~ F ~ I1l [1 ~ I a - __~
_~PiE ~ tt
~~4 \ _- ~_ - / \~
~\ /
GE~~JENTE~H R & D
Overlay District Area
`~
Genentech Annual Report ( April 2003
GENENTECH & CITY CAMPUS PLANNING
Beginning in 1993, the City of South San Francisco City Council, Planning Commission, City
staff and Genentech's Facilities Planner's, worked over a two year period to develop the
Genentech Master Plan and the implementing "Research and Development Overlay District"
ordinance ("R&D Overlay Zone"). The intent of the Genentech Campus Master Plan is to
establish a set of guiding principles for long-range planning and design of Genentech's
buildings and facilities. The Master Plan is not typical in that it does not identify specific
buildings and facilities which will be constructed according to a predetermined timetable.
Instead, the plan provides a set of guidelines for site planning and architecture, traffic,
circulation and parking data, and utilities to guide future development.
Overview of the "R&D Overlay Zone"
The approach contained in the "R&D Overlay Zone" provides both Genentech and the City to
maintain an interactive association, which recognizes the unique nature of the biotech industry
and the relationship of Genentech to the City of South San Francisco as a whole. The Master
Plan and the implementing "R&D Overlay Zoning" rely on review streamlining, campus-wide
application of development requirements (rather than the more typical parcel-by-parcel basis),
and periodic review of development activities. The design guidelines, for example, establish
a "kit of parts" for all future improvements on the campus. Proposed developments are
required to incorporate pertinent guidelines into the project.
How the "R&D Overlay District" Works
The R&D Overlay District is consists of all lands classified on the City's Zoning Map. All
land use policies, regulations, development and design standards, and requirements are set
forth in the General Plan, East of 101 Area Plan and the Zoning Ordinance.
City of South San Francisco General Plan
Adopted in October 1999, the South San Francisco General Plan recognizes that the
biotech/R&D industry is South San Francisco's largest industrial cluster. It is vital that the
City strive to create an environment that is beneficial in realizing this potential and maintains
the City's competitive edge. The General Plan establishes goals/policies for the City and East
of 101 area, such as:
• Establishes an economic development program that promotes the biotechnology/R&D
industrial cluster;
• Encourages the development of R&D campuses;
• Establishes infrastructure capacity;
• Establishes transportation improvements; and,
• Promotes employee amenities, open space and recreation areas.
Genentech Annual Report '] April 2003
City of South San Francisco East of 101 Area Plan
In 1995, The East of 101 Area Plan established goals/policies for the City and East of 101
area that are not in conflict with the General Plan. Although the South San Francisco General
Plan (adopted in 1999) supercedes the East of 101 Area Plan, most of the Plan's original
design, noise, open space, and development standards still apply to campus development.
Specifically, it:
• Encourages economic development;
• Establishes design and development standards for all development; and,
• Encourages regulatory incentives (such as the "R&D Overlay District") for facility-
wide planning.
"R&D Overlay District" Regulations
The Research and Development Overlay District establishes regulations for reclassifying to
and from this district and establishes development standards and requirements within the
district. The district intends to enhance planning and design principles for research and
development facilities. It:
• Establishes requirements for eligible sites;
• Requires preparation of a master plan;
• Requires preparation of design guidelines;
• Establishes permit review procedures; and,
• Allows for development of facility-specific standards.
"Genentech R&D Overlay District"
The Zoning Ordinance establishes the Genentech Research and Development Overlay District
and prescribes planning and design principles for facility-wide development in accordance
with the Genentech facility master plan. It:
• Maps the Genentech properties covered by the "Genentech R&D Overlay District";
• Identifies FAR and parking standards for Genentech properties consistent with the
South San Francisco General Plan;
• Establishes Genentech-specific design guidelines; and,
• Identifies standards that would be applied facility-wide (setbacks, FAR, parking,
signage, building heights, and lot coverage, etc.) for the Genentech campus.
Public-Private Partnership Benefits
Below are specific ways in which the "R&D Overlay Zone" is apublic-private partnership:
(1) Addresses City Economic Development Objectives. The "R&D Overlay
Zone" is a model ordinance developed in coordination with City staff for
facilitating private adaptive re-use/redevelopment of this older industrial
area by providing an incentive for master planning multiple parcels. It also
provides Genentech-Specific Zoning, which contains standards and design
Genentech Annual Report g April 2003
guidelines specific to Genentech that are agreed to by the City and the
company. The Master Plan and "R&D Overlay Zoning" regulations
establish a regulatory incentive for economic development to attract other
biotechnology companies to the East of 101 area by providing afacility-
wide planning mechanism.
(2) Coordinates with the South San Francisco General Plan, the East of 101
Area Plan, and Environmental Impact Reports. The "R&D Overlay Zone"
establishes a larger context for considering Genentech's plans based on the
City's goals for the General Plan and East of 101 Area Plan. It provides a
long-range planning framework for decision-making to ensure adequate
infrastructure within acity-wide context to minimize future impacts and
conflicts, and to avoid potential data or policy inconsistencies.
(3) Addresses On-site Issues. In coordination with the Planning
Commission, Design Review Board and City staff, the "R&D Overlay
Zone" addresses site development issues of City and Genentech concern as
evaluated in the Master Plan (such as parking, facility-wide context for
project review, design, campus improvements, etc.).
(4) Addresses Company Issues. Coordination with the City allows the
planning for and reservation of adequate capacity for company growth
(traffic, utilities, etc.). It also clarifies project review/design criteria,
provides for facility-wide development standards, and maintains some
latitude in Genentech's planning for the use of its facility in response to the
rapid changes in the biotechnology field.
(5) Encourages aesthetic improvements. The "R&D Overlay Zone" permits
comprehensive planning of the campus as a whole facility rather than as
fragmented parcels. It clarifies the scope, criteria, standards, design
guidelines and procedures for future project review so they are tailored to
enhancing the area as a whole.
(6) Balances City need for certainty with R&D/Biotech need for flexibility.
This process addresses site development issues of City concern by
providing afacility-wide context for projects (parking, building and site
plan design). It also recognizes the dynamics of the biotechnology industry
and the rapid changes needed for company growth.
(7) Specifies review criteria and thus permits a streamlined review process
for smaller projects. The "R&D Overlay Zone" clarifies the review
process for specific buildings or other improvements by establishing the
criteria and facility-wide context for future project review under design
guidelines agreed upon by the City and Genentech. It provides a
mechanism to implement City policies by tying together the East of 101
Genentech Annual Report 9 April 2003
Plan, existing zoning and the Genentech Corporate Facility Master Plan.
This approach establishes agreed upon procedures and project review
criteria/design guidelines that are linked to facility improvements.
Genentech Annual Report 10 April 2003
Consistent Campus
Architecture &
Character
Public Art and Plazas
Employee Espresso Bars
And Meeting Areas
~* ~
~z
I
. ~~
~~
~-it~
_..r-:
._x
-:'. r
:z_
Genentech Annual Keport ] j April 2003
~ ,_
GENENTECH 2003 CAMPUS DEVELOPMENT & BUILDOUT
Genentech Campus Buildout
The Genentech Corporate Facilities Master Plan establishes guidelines for long-range
planning and design in the Genentech campus. The Overlay District includes specific
development standards that limit the approved Buildout in both gross floor area and. The
following table summarizes the current Genentech campus size and Buildout in Apri12003:
Site Area Site Area Building Floor Area Parking
(acres) (s uare feet) Area Ratio Inventor
Facility
Total 97.3 3,992,935 2,138,315 0.53 3,731
City of South San Francisco/Genentech Coordination
The Genentech Corporate Facilities Master Plan was designed to ensure consistency with
existing South San Francisco General development policies. The Master Plan assures that
Genentech's growth fits within acity-wide development context, adopted in the South San
Francisco General Plan, to minimize future impacts and conflicts or policy inconsistencies.
The following are examples of ways in which Genentech has tried to reduce infrastructure
expansion needs and coordinate campus development with the City of South San Francisco:
• Genentech has supported the City's transportation improvement programs
(Transportation Demand Management, CALTRANS and BART ridership, shuttle
service, in-lieu parking, guaranteed ride home for employees, Downtown Dasher
service and parking enforcement program).
• Genentech has initiated campus improvements -- such as a childcare center, employee
services, and full-service cafeteria -- that minimize the need to go off-campus or out of
the East of 101 area.
• Genentech continues to pay its "fair share" for off-site improvements, such as the East
of 101 Traffic Impact Fee.
• Genentech is implementing programs to minimize the need for sewer and water.
• Genentech's First Alert Team (coordination between Police, Fire, Security)
coordinates safety procedures with the City.
• Genentech enforces safe work environment rules.
• Genentech coordinates development permits with the City Managers Office, Police
Department, Building/Fire Prevention Division, Economic and Community
Development Department/Planning Division, Public Works Department/Bngineering
Division.
Genentech Annual Report 12 April 2003
2002-03 Accomplishments
The Genentech Corporate Facilities Master Plan establishes guidelines for long-range
planning and design in the Genentech campus.
Lower Campus
• B6 (120,575 square feet new building) was completed in June 2002. It provides
support to manufacturing operations and allows centralization of administrative
functions and related support.
• The Central Spine Project was completed in October 2002 and it unites the lower
campus (B5, 6, 7, 8 and 9) through a system of landscaped vehicular and pedestrian
circulation paths as well as a plaza between B6 and B8.
Mid Campus
• The Founder's Research Center II (B 13, B 14 and B 15), totaling 287,550 square feet
for R&D, Laboratory and Office uses, is under construction and will be completed in
December 2003.
• B36 (25,900 square feet) is being remodeled to provide additional office space and is
scheduled for completion in May 2003.
Upper Campus
• B56 and B57 were demolished in October 2002 to allow for construction of B32.
• B32 (125,000 square feet of new building) will be completed in March 2004. It will
provide additional office space for the Upper Campus.
Recent Overlay District Expansion
The Genentech Master Plan and "R&D Overlay District" have been used to process such
projects as Buildings B7, B25, B26, B6 and FRCII (Buildings B 13, B 14 and B 15). Campus
improvements have been made to circulation and parking, lighting, landscaping
improvements, Kaufmann Court, cafeteria planning, Merck site planning, building color and
signage program, outdoor amenities, and central spine development. In 2001, the City
approved Genentech's plans to rezone four parcels from Planned Industrial to the Genentech
Research & Development Overlay District. The new parcels increased the size of the
Genentech Research and Development Overlay District from 82.6 acres to 97.3 acres.
Genentech Annual Report 13 April 2003
New Construction & Completed Projects
2003
-_----+-
~,~
~ ., ~
~f~ ~a Mt` '~~ _ r ~'X. y~~ - o I,~ ~ iii. S ,~ i
.~.-+ t.e-, a-..mot .T~«S r. - -.,~cPSV-.~ w- ~~.~.. . ~ m
.sw., .. -,cat .~,.,,r.~y
Mid-Campus, Founders' Research Center II
~~~~
,.'~. .. .fi_. _~~
Lower Campus, Central Spine
April ?003
Gcncntech Annual Report 14
Upper Campus, B32
GENENTECH TRANSPORTATION & PARKING
MANAGEMENT
Transportation Demand Management Program
In 2001, the City of South San Francisco adopted the Transportation Demand Management
(TDM) Ordinance, which establishes specific performance standards to judge the success of a
company's TDM Plan. Traffic flow at Genentech is managed through traffic improvements
and programs, such as TDM programs, internal shuttle service, and day care in East of 101
area. Genentech also provides incentives/assistance to increase CALTRAIN and BART
ridership, finances (with SamTrans) the free shuttle service, seeks partnership activities,
encourages in-lieu parking, implements transportation improvements, and provides its own
parking enforcement programs.
Genentech is operating Transportation Demand Management (TDM) programs that aim at
reducing the use of private cars by their employees. These programs address daily commute-
to-work trips as well as business-related travel during the day between the various campuses
and downtown South San Francisco. Programs offered to Genentech employees include:
• New employees are provided an explanation of choices of available TDM services and
personal consultation is available for new employees.
• Periodic dissemination of TDM information provided to all employees.
• Carpool/Vanpool matching services provided for carpool/vanpool interested
employees.
• Sale of transit tickets (for BART, CalTrain, Sam Trans, Muni and Golden Gate Bridge
Transit) at the Building B 1 Genenstore (an average of 244 tickets per month have been
sold thus far in 2002).
• Payroll deductions for purchase of transit passes, and income tax benefit as allowed by
law.
• Free employee shuttle bus service during commute hours to the Glen Park BART
Station in San Francisco and South San Francisco CalTrain Station (an estimated 15%
of employees, or 730 people, utilize these shuttle services).
• Free campus-wide on-site shuttle buses between parking lots and buildings operating
between 8 am and 6 pm and daily round trip shuttles to Genentech's Vacaville
Campus.
• Free mid-day service on the Dasher Shuttle to downtown South San Francisco (prior
booking is required) and the Schoeber's Gym Shuttle (an estimated 30 employees per
month utilize the Dasher Shuttle).
• Vanpool coordination with the VAN RIDES and RIDES organization (an estimated
120 employees participate in these "pooling" arrangements).
• Flextime and telecommuting options available to employees.
• Shift-work allows many employees to travel off-peak.
Genentech Annual Report 15 April 2003
• Bike storage lockers are located at numerous buildings and bike racks, showers and
locker facilities are available at most Genentech buildings (an estimated 10-15
employees utilize this commute option).
• "Clunker Loaner Blue Bikes" for free use on campus (an estimated 25-30 bikes are in
the program).
• An "Emergency Ride Home" program for participants in the transit and vanpool
programs.
• Convenience services on campus such as ATM's, credit union, hair salon barber shop,
dental facility, prescription delivery, film developing, laundry/dry cleaning etc. to
minimize off-campus trip making.
Audit of the Genentech Parking Inventory
The Genentech R&D Overlay District and Genentech's Master Plan requires a "Facility-
Wide" approach to parking. This strategy addresses the adequacy of the overall, campus- wide
parking situation while assuring that "the available parking will be allocated in such a way
that at least 75 percent of the parking demand of each sub-facility is satisfied within that sub-
area." In 2001, the City approved Genentech's request to provide parking at a rate of 1.60
spaces per 1,000 square feet of building area.
In March 2003, Fehr & Peers, Transportation Consultants, reviewed the "Genentech 2003
Parking Audit" to document whether Genentech is currently providing parking at the
permitted rate given the current building area and the number of usable parking spaces.
Parking Inventory
Fehr & Peers Associates staff conducted field visits in May 2002 to count the number of
parking spaces in each lot and in the parking structure. Parking spaces for company vehicles,
motorcycles, the disabled (handicapped spaces), employees, visitors, loading spaces (that are
available for employees parking), inactive spaces, and the public (access to the Bay Trail)
were tabulated separately. Inactive spaces are those that are covered with construction trailers
or that are located within construction zones.
Genentech staff updated the parking inventory in March 2003 to add and subtract parking
spaces to reflect current construction activities on the campus. The number of available spaces
increased on the Lower Campus partly because construction activities ending on that sub
campus, and on the Mid Campus due to decreased construction activity at FRC II. The
number of available spaces decreased in the Upper Campus due to new construction activities
for Building 32. In addition, Genentech is currently leasing 85 parking spaces at the nearby
UCSF building on the Lower Campus. These spaces are available for Genentech employees
and were included in the audit. The results are presented in Table A-1 (attached).
The inactive spaces and spaces for the public are not included in the parking audit. Therefore,
there are 3,731 usable/available spaces.
Genentech Annual Report 16 April 2003
Cam us Area Usable S aces
Lower Cam us 1,828
Mid Cam us 704
Upper Campus 1,199
Total 3,731
Building Inventory
Genentech provided an inventory of the buildings on site. It is presented in Appendix B. The
total building area analyzed in the Parking Audit is 2,138,315 square feet.
The Parking Audit indicates that Genentech is currently providing parking at a rate of 1.74
spaces per 1,000 square feet of building area. Therefore, the campus is currently meeting the
approved parking rate.
Genentech Annual Report 1'] April 2003
SAN FRANCISCO /PENINSULA BAY TRAIL ALIGNMENT
The San Francisco Bay Conservation and Development Commission (BCDC) is authorized to
implement the McAteer-Peers Act requirements for "maximum feasible public access" to and
along the waterfront with the shoreline band. The San Francisco Bay Conservation and
Development Commission has jurisdiction over the shoreline band adjacent to the Genentech
campus.
In 1968 BCDC designated the shoreline area between Bay West Cove and Point San Bruno as
a "Priority Park Area", which emphasizes public access and recreational uses. Permit Area 1
is located in the "Priority Park Area" between the UPS property and Point San Bruno.
Portions of Genentech three parking lots for employees and visitors are constructed within the
100 feet shoreline area.
The original BCDC permit created two public parking areas and the construction of a four feet
wide Bay Trail. The BCDC permit allows the public to gain access to the shoreline where
parking is otherwise not available, and allow the public to sit in their cars and enjoy the scenic
views when the site is uncomfortably windy. Genentech is working with BCDC staff to
upgrade the existing Bay Trail segment on the Genentech campus. The proposed
improvements include widening the existing Bay Trail and installing new landscaping.
Genentech conducted on site meetings with BCDC staff last year to review proposed
landscape design and maintenance of BCDC areas on Forbes Blvd. The BCDC project
representative has agreed in concept with the plan and landscaping design for the BCDC zone
from the UPS facility to the Pt. San Bruno fishing "point". Genentech will put the project out
to bid and complete all work in 2003.
Genentech has also completed an in-depth study of different approaches for completing the
BCDC trail connection from the Pt. San Bruno fishing "point" to the BCDC trail connection
at the Slough property on East Grand Ave. Based on this analysis, Genentech has completed
a conceptual trail plan, including associated cost. Genentech will begin discussions with
BCDC this year, with the intent of reaching an agreement on both the project scope and
implementation plan for this section of the trail.
Genentech Annual Report 1 g April 2003
Appendix A
Genentech Research and Development Overlay District Current Facility
Summary Apri12003
Genentech Annual Report 19 April 2003
Genentech Research & Development Overlay District
Current Facility Summary (March 2003)
Genentech Building Parcel Address & Location Site Area Site Area Building Area FAR Building
Number acres
( )
(s.f.)
(s.f.)
Footprint
(a)
(b)
(c)
(d)
(e) (f) s.f.
(9)
Lower Campus
1 & 4 1 DNA/ 800 Forbes 10.377 274,000 274,000 165,600
East Lot Forbes shoreline 0.983 42,819 0 0
West Lot Forbes shoreline 1.63 71,003 0 0
3 44 DNA Way 4.489 195,541 190,000 72,600
5 & 5T 22 DNA Way 3.308 144,096 178,240 91,000
6 600 Forbes 120,575
7 700 Forbes 4.16 181,210 259,600 92,202
8 & 9 650/640 Forbes 9.724 423,577 262,700 209,100
644 Forbes 3.183 138,651 0 0
PSI (formerly B22) 632 Forbes 1.52 0
Subtotal 1,285,115
Mid Campus
FRC I (10, 11, 12) 99/ 101/ 103 DNA Way 16.951 738,386 279,800 68
100
East Grand Site 500 Grand East Grand 3.685 160,519 0 ,
0
36 1776 Grandview Drive 1.2 52,272 25,900 25,900
37 353 Point San Bruno Blvd. 0.73 31,799 16,870 16,870
59 105 DNA Way 13,000
Subtotal 335,570
Upper Campus
2 1475 Grandview 3.067 133,599 58,000 48
000
24, 25, 26, 55 1600/ 1500/ 1526/ 1650 Grandview 13.527 589,236 298,230 ,
0
20, 21 1000/1200 Grandview 6 261,317 125,000 84
264
Grandview Site II 1541-1599 Grandview 2.708 117,960 0 ,
0
Grandview Site I 1604-1757 Grandview 7.211 314,111 0 0
28 550 Grandview 2.82 122,839 36,400 36,400
Subtotal 517,630
Facility Total 97.2730 3,992,935 2,138,315 0.54 910,036
Genentech Annual Report 20 April 2003
Genentech Building
Number Genentech Research & Development Overlay District
Projected Demolition & New Construction through 2004
Parcel Address & Location Building Area (s.f.) Building Footprint
(s f )
Other
(a) (b) (c) (d) (e)
Lower Campus
5T 22 DNA Way -1,240 -1,240 Demo Q1 04
Mid Campus
FRC II (13/ 14/ 15) 107/ 109/ 111 DNA Way 287,550 90,460 Q4 03
659 105 DNA Way -13,000 -13,000 Demo Q4 03
637 (Formerly 61) 353 Point San Bruno Blvd. -16,870 -16,870 Demo Q4 03
Upper Campus
32 1541 Grandview Drive 125,000 25,000 Q1 04
Additional Bldg. Area 381,440 84,350
Adjusted Facilites Total 2,519,755 994,386
Genentech Annual Report 21 April 2003
Appendix B
Genentech 2002 Parking Audit Apri12003
Genentech Annual Report 22 April 2003
FEHR & PEERS
TRANSPORTATION CONSULTANTS
MEMORANDUM
Date: Apri17, 2003
To: Lisa Sullivan, Director of Facilities Planning
Genentech, Inc.
From: .Jane A. Bierstedt, P.E.
Subject: Genentech 2003 Parking Audit io3s-s76
The purpose of this parking audit is to document that Genentech, Inc. is currently providing
parking at rate of at least 1.60 spaces per 1,000 square feet of building area, given the current
building area and number of usable parking spaces.
Parking Inventory
Fehr & Peers Associates staff conducted field visits in May 2002 to count the number of parking
spaces in each lot and in the parking structure. Parking spaces for company vehicles,
motorcycles, the disabled (handicapped spaces), employees, visitors, loading spaces (that are
available for employees parking), inactive spaces, and the public (access to the Bay Trail) were
tabulated separately. Inactive spaces are those. that are covered with construction trailers or that
are located within construction zones.
Genentech staff updated the parking inventory in March 2003 to add and subtract parking spaces
to reflect current construction activities on the campus. The number of available spaces increased
in Zones LS and L7, partly because construction activities ended on the lower campus, and in
Zones M13A and M14 due to decreased construction activity at FRC II. The number of available
spaces decreased in Zone U21/LT22 due to new construction activities for Building 32. In
addition, Genentech is currently leasing 85 parking spaces at the nearby UCSF building. These
spaces are available for Genentech employees and were included in the audit. The results are
presented in Table A-1 (attached).
The inactive spaces and spaces for the public are not included in the parking audit. Therefore,
there are 3,731 usable/available spaces.
255 N. Market Street, Suite 200 San Jose, CA 95110 (408) 278-1700 Fax (408) 278-1717
www.fehrandpeers.com
FEHR & PEERS
TRANSPORTATION CONSULTANTS
Building Inventory
Genentech provided an inventory of the buildings on site. It is presented in Table A-2. The total
building area is 2,138,315 square feet. The largest changes from the 2002 audit are the
completion of Building 6 and the removal of Buildings 56 and 57.
The projected demolition and new construction through 2004 is presented in Table A-3. The
projected net-addition of building area is 381,440 square feet. Genentech also anticipates
regaining 300 additional parking spaces that are currently inactive due to construction activity.
Parking Ratio
The parking ratio is determined by dividing the number of parking spaces by the building size in
1,OOOs of square feet, or 3,731/2,138. The result is 1.74 spaces per 1,000 square feet.
Conclusions
Genentech, Inc. is currently providing parking at a rate of 1.74 spaces per 1,000 square feet of
building area. Therefore, it is currently exceeding the mandated rate.
2
M
0
0
N
ti
.`
L1
Q
M
O
O
N
...
O
.~.
C
C
O
C
..Y
N
a
C)
N_
D
Q ~
_N >
.n O
r ^C
W
Q
0
a~
t
L
N
N
U
N
.~.
C
N
C
N
W
J
m
CQ
~
~
M
mot'
CA
~
to
C7~
CO
00
O
~
~
M
~
N
O
.-
CA
N
C10
r
[t
~
N
00
r
M
M
~
ti
In
O
O
In
~
O
~
~
r
O
M
CO
V
~
~
N
~
r
~
C'7
M
r-
OS
r
t-
M
1~.
M
W
Z
' LL
~
m ~',
~
U
N
M
m
~t'
ttJ c
o
U
~
N
~
' ~
~
O
N r
"'~ ~
J ~
J ~
~ N
J M
J c!'
J tn
J
J l`
J CC)
J p)
J
~ r
,
~
~
~
~
~
~
~
~ CO
~ 1
~ o0
~ CA
~ O
~
r d
~ U
~
~ ~ ~ N C1
U
~, ~_
~ L
,
.-.~ a G
a ~
v U ~ U ~
[G
~ ~ U
~
~
'
~ J ~
1
1
f
N
N
U
f0
C2
N
U_
a
O
C
N
U
c~
L2
y
Appendix C
Phase 1 BCDC Bay Trail Alignment Apri12003
Genentech Annual Report 2C April 2003
N
0
q~
1
~~ <~
cW
~~ ~~
~ ~
g z
m
e 8 ~
~~~~o ~
T ;
~~~~
o~ zx m~
F~ ~Fi~W ~
U ~ f~l I
NU ~ ~ ~.
~a ~I L
~'Z
~ --
r '~~
~.,
3
~
~~
;~~
a~
}R
F
C
py
f-
/I ~
1 Y•:
~ ~ r ~ ~~
Genentech Annual Report 27 April 2003